AI
LLY icon

Atom Investors’s Eli Lilly LLY Stock Holding History

Atom Investors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-324
Closed -$253K – 732
2025
Q2 		$253K Buy
324
+19
+6% +$14.8K 0.02% 467
2025
Q1 		$252K Buy
305
+1
+0.3% +$832 0.03% 385
2024
Q4 		$235K Buy
+304
New +$252K 0.03% 407
2024
Q3 		– Sell
-1,047
Closed -$948K – 543
2024
Q2 		$948K Buy
1,047
+601
+135% +$481K 0.09% 260
2024
Q1 		$347K Buy
+446
New +$317K 0.04% 387
2023
Q3 		– Sell
-592
Closed -$278K – 473
2023
Q2 		$278K Buy
+592
New +$248K 0.11% 200
2023
Q1 		– Sell
-1,037
Closed -$379K – 288
2022
Q4 		$379K Buy
+1,037
New +$368K 0.19% 109
2020
Q4 		– Sell
-3,704
Closed -$548K – 486
2020
Q3 		$548K Buy
+3,704
New +$573K 0.05% 246

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Atom Investors's LLY Position: Q3 2025 in Review

Atom Investors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 324 shares — an estimated $253K sold.

Atom Investors first reported a position in LLY in Q3 2020 and held it in 8 quarters. The position peaked at $948K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Atom Investors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 324 Eli Lilly shares in Q3 2025, an estimated $253K.
  • Atom Investors first reported a position in Eli Lilly in Q3 2020 and held it in 8 quarters.
  • Atom Investors's Eli Lilly position peaked at $948K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.